Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bioness Acquires PoNS System

What are you searching for?

Sign in
OEM News

Bioness Acquires Portable Neuromodulation Stimulator (PoNS) System

The addition expands the company’s capabilities into non-invasive central neuromodulation.

Author Image

By: Sam Brusco

Associate Editor

Bioness Medical has acquired the PoNS (Portable Neuromodulation Stimulator) system product line.

The addition expands the company’s capabilities into non-invasive central neuromodulation. It also reinforces Bioness’ position as a comprehensive provider of solutions for patients with gait and balance disorders resulting from neurological injury or disease.

Adding the PoNS system expands the company’s platform to include non-invasive neuromodulation delivered via the tongue, stimulating cranial nerve pathways to promote neuroplasticity and functional recovery. PoNS has been studied in patients with chronic neurological conditions, showing improvements in gait and balance when used as part of a supervised rehabilitation program.

“PoNS technology represents a differentiated approach to neuromodulation that complements our core FES platform,” said Todd Cushman, CEO of Bioness Medical. “Bioness has built deep relationships with rehabilitation providers over decades. With PoNS, we expand beyond peripheral stimulation into central neuromodulation—offering clinicians a non-invasive therapy that engages neural pathways involved in balance and gait. This positions Bioness to deliver more comprehensive, multi-modal rehabilitation solutions to patients.”

The company’s established portfolio includes L300 Go, H200 Wireless, and the Vector Gait & Safety system. Together with PoNS, the technologies allow clinicians to address both peripheral motor activation and central neural network modulation in a unified rehabilitation approach.

This marks Bioness’ third acquisition since becoming and independent neurorehabilitation company after its acquisition by Accelmed Partners in December 2024.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Add Orthopedic Design & Technology as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters

Topics